In our study, CD4+ memory T cells in the lower FRGScore group were more active, and CD4+ helper T cells provide an opportunity to enhance T cell response to tumor-associated antigens without deleterious autoimmunity [18]. This evidence concerns the gene CD4 and neoplasm.